Effects of low-dose IV ketamine on peripheral and central pain from major limb injuries sustained in combat

Pain Medicine (United States)

Volumn 14, Issue 7, 2013, Pages 1088-1100

  Polomano, Rosemary C ^a,b   Buckenmaier, Chester C ^e,f   Kwon, Kyung H ^e   Hanlon, Alexandra L ^a   Rupprecht, Christine ^h   Goldberg, Cynthia ^g   Gallagher, Rollin M ^b,c,d  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Pain Management Program   (United States)

^d Pain Policy Research and Primary Care   (United States)

^e Defense and Veterans Center for Integrative Pain Management   (United States)

^f Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h Inova Mount Vernon Hospital   (United States)

Author keywords

Acute Pain; Chronic Pain; Ketamine

Indexed keywords

KETAMINE; MORPHINE;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFECT; HUMAN; LIMB INJURY; LIMB PAIN; LOW DRUG DOSE; MALE; RETROSPECTIVE STUDY;

EID: 84880615116     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12094     Document Type: Article

References (38)

1. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol 2008;182:313-333.
2. Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R. Ketamine: New indications for an old drug. Curr Drug Targets 2005;6:789-794.
3. Noppers I, Niesters M, Aarts L, etal. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother 2010;11:2417-2429.
4. Carstensen M, Møller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: A qualitative review of randomized trials. Br J Anaesth 2010;104:401-406.
5. Hurstveit O, Maurset A, Øye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, and muscarinic receptors. Pharmacol Toxicol 1995;77:335-359.
6. Chizh BA. Low dose ketamine: A therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol 2007;21:259-271.
7. Stubhaug A, Breivik H, Eide PK, Kreunen M, Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 1997;41:1124-1132.
8. Minville V, Fourcade O, Girolami JP, Tack I. Opioid-induced hyperalgesia in a mice model of orthopaedic pain: Preventive effect of ketamine. Br J Anaesth 2010;104:231-238.
9. Luft A, Mendes FF. Low S(+) ketamine doses: A review. Rev Bras Anestesiol 2005;55:460-469.
10. Buvanendran A, Kroin JS. Useful adjuvants for postoperative pain management. Best Pract Res Clin Anaesthesiol 2007;21:31-49.
11. Suzuki M. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management. Curr Opin Anaesthesiol 2009;22:618-622.
12. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138.
13. Harding G, Schein JR, Nelson WW, etal. Development and validation of a new instrument to evaluate the ease of use of patient-controlled analgesic modalities for postoperative patients. J Med Econ 2010;13:42-54.
14. Palangio M, Morris E, Doyle RT Jr, Dornseif BE, Valente TJ. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther 2002;24:87-99.
15. Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill; 1994.
16. O'Donnell ML, Creamer M, Bryant RA, Schnyder U, Shalev A. Posttraumatic disorders following injury: An empirical and methodological review. Clin Psychol Rev 2003;23:587-603.
17. Kennedy JE, Leal FO, Lewis JD, Cullen MA, Amador RR. Posttraumatic stress symptoms in OIF/OEF service members with blast-related and non-blast-related mild TBI. NeuroRehabilitation 2010;26:223-231.
18. Himmelseher S, Durieux ME. Ketamine for perioperative pain management. Anesthesiology 2005;102:211-220.
19. Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2006;(1):CD004603.
20. Deng GF, Zheng JP, Wang S, Tian B, Zhang SG. Remifentanil combined with low-dose ketamine for postoperative analgesia of lower limb fracture: A double-blind, controlled study. Chin J Traumatol 2009;12:223-227.
21. Suzuki M, Haraguti S, Sugimoto K, etal. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology 2006;105:111-119.
22. Sigtermans MJ, van Hilten JJ, Bauer MC, etal. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009;145:304-311.
23. Eichenberger U, Neff F, Sveticic G, etal. Chronic phantom limb pain: The effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 2008;106:1265-1273.
24. Kvarnström A, Karlsten R, Quiding H, Emanuelsson BM, Gordh T. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol Scand 2003;47:868-877.
25. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 2001;91:177-187.
26. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain 1996;64:283-291.
27. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994;58:347-354.
28. Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 2000;20:246-252.
29. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: A double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995;18:360-368.
30. Bell RF, Dahl JB, Moore RA, Kalso E. Peri-operative ketamine for acute post-operative pain: A quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand 2005;49:1405-1428.
31. Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence-based review. Anesth Analg 2003;97:1730-1739.
32. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother 2006;60:341-348.
33. Chazan S, Ekstein MP, Marouani N, Weinbroum AA. Ketamine for acute and subacute pain in opioid-tolerant patients. J Opioid Manag 2008;4:173-180.
34. Nikolajsen L, Hansen CL, Nielsen J, etal. The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input. Pain 1996;67:69-77.
35. Hayes C, Armstrong-Brown A, Burstal R. Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: A randomized, controlled trial. Anaesth Intensive Care 2004;32:330-338.
36. Azari P, Lindsay DR, Briones D, etal. Efficacy and safety of ketamine in patients with complex regional pain syndrome: A systematic review. CNS Drugs 2012;26:215-228.
37. Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev 2011;(12):CD006380.
38. Wolff A, Vanduynhoven E, van Kleef M, etal. 21. Phantom pain. Pain Pract 2011;11:403-413.